Axsome receives FDA Orphan Drug designation for narcolepsy drug

Drug Discovery |  News | 0 Comment | 17 Oct, 2018

Singapore - Axsome Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, received on Tu...Read more

FDA issues new guidance for developers of complex generics

Drug Discovery |  News | 0 Comment | 10 Oct, 2018

 Singapore - The FDA has released new guidance documents aimed at advancing development of generic versions of transdermally and topically administered drugs, formulations th...Read more

Novartis’ crizanlizumab relieves patients from sickle cell pain crisis

Drug Discovery |  News | 0 Comment | 10 Oct, 2018

Results from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab, a humanized anti-P-selectin monoclonal antibody being investigated for the treatment of sickle cell disease ...Read more

J&J abandons partnership for Geron’s cancer drug

Drug Discovery |  News | 0 Comment | 04 Oct, 2018

Singapore - Johnson & Johnson has dissolved its four-year-old partnership with Geron for cancer drug imetelstat, wiping two-thirds off the biotechs share price at a stroke. J&...Read more

New drug blocks pancreatic cancer growth

Drug Discovery |  News | 0 Comment | 28 Sep, 2018

A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mice, according to a study led by Cedars-Sinai.  The study, publi...Read more

Alexion to acquire Syntimmune

Drug Discovery |  News | 0 Comment | 26 Sep, 2018

Alexion Pharmaceuticals and Syntimmune have entered into a definitive agreement for Alexion to acquire Syntimmune, a clinical-stage biotechnology company developing antibody therapeutics ta...Read more

Anaeropharma Science signs research agreement with Astellas

Drug Discovery |  News | 0 Comment | 25 Sep, 2018

Anaeropharma Science Inc. headquartered in Tokyo (hereafter "Anaeropharma") has announced that Anaeropharma and Astellas Pharma Inc. headquartered in Tokyo (hereafter "Astellas") ...Read more

Accenture, Merck, Amazon partner to advance drug innovation and research

Drug Discovery |  News | 0 Comment | 18 Sep, 2018

Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS), will launch a cloud-based informatics research platform de...Read more

Pfizer receives Breakthrough Therapy designation for inhibitor drug

Drug Discovery |  News | 0 Comment | 06 Sep, 2018

Singapore - Pfizer announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthrough Therapy designation from the U.S. Food and Drug Administration (...Read more

China approves first "Made in China" cancer drug

Drug Discovery |  News | 0 Comment | 06 Sep, 2018

China-based Chi-Med has announced that fruquintinib capsules have been granted approval for drug registration by the National Medical Products Administration of China (“NMPA”, f...Read more

BeiGene Announces Acceptance of its First NDA for Zanubrutinib

Drug Discovery |  News | 0 Comment | 28 Aug, 2018

China's commercial-stage biopharmaceutical company BeiGene,   recently announced the acceptance by the China Drug Administration (CDA) of a new drug application (NDA) fo...Read more

FDA approves first drug for neurotrophic keratitis

Drug Discovery |  News | 0 Comment | 23 Aug, 2018

Singapore- The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear ...Read more

Strides Pharma receives USFDA nod for two key ANDAs

Drug Discovery |  News | 0 Comment | 22 Aug, 2018

India's Strides Pharma  has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, received ANDA “acceptable for filing” corre...Read more

GIC receives govt funding for immuno-oncology project

Drug Discovery |  News | 0 Comment | 22 Aug, 2018

Edmonton's General Intermediates of Canada Inc. (GIC) has received conditional funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) related...Read more

Roche's Alecensa receives 'priority review' designation from CNDA

Drug Discovery |  News | 0 Comment | 21 Aug, 2018

Roche  recently announced that the China National Drug Administration (CNDA) has granted marketing authorization for Alecensa (alectinib) as a monotherapy treatment for patients with a...Read more

HitGen collaborates with LG Chem

Drug Discovery |  News | 0 Comment | 20 Aug, 2018

HitGen Ltd has announced a multi-year major drug discovery research collaboration with LG Chem to identify novel small molecule leads for targets of interest. In this collaboration, HitGen ...Read more

Blueberry Therapeutics raises £10M funding to develop nanomedicines

Drug Discovery |  News | 0 Comment | 16 Aug, 2018

Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines for difficult to treat skin and nail infections, has successfully com...Read more

Multi- institutional alliance to develop anti-aging drugs

Drug Discovery |  News | 0 Comment | 16 Aug, 2018

The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial intelligence (AI) to discover and develop novel anti-aging therapeutics ...Read more